Keros Therapeutics, Inc.
Status: Publicly traded
Direct answer
Keros Therapeutics, Inc. is publicly traded on NASDAQ under the ticker KROS.
Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and musculoskeletal conditions that currently lack adequate treatment options. Its flagship protein therapeutic, KER-050, is being advanced to address diminished blood cell counts (cytopenias), specifically anemia and...
Can you invest in Keros Therapeutics, Inc.?
Yes. Keros Therapeutics, Inc. trades publicly on NASDAQ as KROS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Keros Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.